Research in social & administrative pharmacy : RSAP
-
Res Social Adm Pharm · Aug 2019
Pharmacist utilization of prescription opioid misuse interventions: Acceptability among pharmacists and patients.
Pharmacists have played an increasingly critical role in combatting the epidemic of prescription opioid misuse and abuse, due in large part to their accessibility and their function as gatekeepers to prescription medication. Throughout the United States, pharmacists have crafted interventions designed to prevent, identify, and manage opioid misuse and abuse. In order to be effective, however, both patients and pharmacists must comply with interventions. To ensure compliance with proposed pharmacy-based interventions, both patients and pharmacists must recognize patient education, screening and counseling for substance misuse and abuse as acceptable components of pharmacy practice.
-
Res Social Adm Pharm · Aug 2019
Using the theory of planned behavior to investigate community pharmacists' beliefs regarding engaging patients about prescription drug misuse.
Opioid misuse causes over 50,000 deaths in America each year. Prescription drug monitoring program (PDMP) databases serve as a useful decision analysis tool in managing patients with known or potential opioid use disorder (OUD). To date, however, little research has sought to determine how pharmacists use PDMPs to engage patients with potential OUD. ⋯ The results illustrate some of the challenges faced by community pharmacists when considering engagement of patients with misuse of prescription opioids. Addressing these barriers to patient engagement is critical to increasing pharmacists' willingness to engage patients with potential OUD.
-
Res Social Adm Pharm · Aug 2019
Routine opioid outcome monitoring in community pharmacy: Pilot implementation study protocol.
Increases in opioid use and related harms such as mortality are occurring in many high income countries. Community pharmacists are often in contact with patients at risk of opioid-related harm and represent an ideal point for intervention. Best practice in monitoring opioid-related outcomes involves assessing analgesia, pain functioning, mood, risks and harms associated with opioid use. Community pharmacists are well-placed to undertake these tasks. ⋯ Our study will examine changes in pharmacists' knowledge and confidence to deliver the SBI. Through the implementation pilot, we will establish the feasibility and acceptability of a pharmacist SBI that aims to improve monitoring and clinical management of patients who are prescribed opioids.
-
Res Social Adm Pharm · Aug 2019
Rx for addiction and medication safety: An evaluation of teen education for opioid misuse prevention.
Rhode Island (RI) ninth graders report lifetime nonmedical use of prescription opioids (NMUPO) of 8.9%. NMUPO is associated with transition to heroin use, opioid overdose, and death. ⋯ Students reported significant NMUPO prevalence. Ninth grade students' knowledge and confidence of opioid misuse, overdose response, and recovery resources increased following the delivery of a multi-modal interactive substance use disorder curriculum. Community, school, and student-level interventions are needed to reduce NMUPO.
-
Res Social Adm Pharm · Aug 2019
An opioid dispensing and misuse prevention algorithm for community pharmacy practice.
Prescription opioid abuse has rapidly increased in recent years and is now considered a national epidemic by the United States government. Community pharmacies are at the forefront of opioid abuse, given their role in dispensing opioid prescriptions. Despite this role, however, there are few known guidelines to help community pharmacists navigate the process of detecting and managing prescription opioid abuse. ⋯ Future steps should explore the feasibility of using the algorithm in different community settings, and determine the algorithm's impact on the number of prescription opioids dispensed and the number of individuals referred to prescribers for discussions about possible prescription opioid abuse.